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Abstract
Background: Adequate and intensive rehabilitation is an important requirement for successful total knee arthroplasty.
Although research suggests that Continuous Passive Motion (CPM) should be implemented in the first rehabilitation phase after
surgery, there is substantial debate about the duration of each session and the total period of CPM application. A Cochrane
review on this topic concluded that short-term use of CPM leads to greater short-term range of motion. It also suggested,
however, that future research should concentrate on the treatment period during which CPM should be administered.
Methods: In a randomised controlled trial we investigated the effectiveness of prolonged CPM use in the home situation as an
adjunct to standardised PT. Efficacy was assessed in terms of faster improvements in range of motion (RoM) and functional
recovery, measured at the end of the active treatment period, 17 days after surgery.
Sixty patients with knee osteoarthritis undergoing TKA and experiencing early postoperative flexion impairment were
randomised over two treatment groups. The experimental group received CPM + PT for 17 consecutive days after surgery,
whereas the usual care group received the same treatment during the in-hospital phase (i.e. about four days), followed by PT
alone (usual care) in the first two weeks after hospital discharge.
From 18 days to three months after surgery, both groups received standardised PT. The primary focus of rehabilitation was
functional recovery (e.g. ambulation) and regaining RoM in the knee.
Results: Prolonged use of CPM slightly improved short-term RoM in patients with limited RoM at the time of discharge after
total knee arthroplasty when added to a semi-standard PT programme. Assessment at 6 weeks and three months after surgery
found no long-term effects of this intervention Neither did we detect functional benefits of the improved RoM at any of the
outcome assessments.
Conclusion: Although results indicate that prolonged CPM use might have a small short-term effect on RoM, routine use of
prolonged CPM in patients with limited RoM at hospital discharge should be reconsidered, since neither long-term effects nor
transfer to better functional performance was detected.
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Background
With the ageing of the population, the prevalence of
degenerative joint diseases is increasing. Reports show
that over a one-year period, 25% of people over 55 years
have a persistent episode of knee pain, of whom annually
about one in six consult their general practitioner, in both
the UK and the Netherlands [1]. The prevalence of painful
disabling knee osteoarthritis in people over 55 years is
10% [2], of whom one quarter are severely disabled. In all,
over 300,000 Dutch residents currently suffer from knee
osteoartritis (OA). Total Knee Arthroplasty (TKA) is a
common intervention that can enhance the quality of life
for patients with knee OA. Over 7500 TKAs are performed
in Dutch hospitals every year. In 2004, more than 160
TKAs were performed at the Maastricht University Hospi-
tal.
Adequate and intensive rehabilitation is an important
requirement for successful TKA. The primary focus of early
rehabilitation is to prepare patients for discharge from the
hospital as soon as possible after their operation. Because
restricted knee range of motion (RoM) affects functional
activities, knee RoM is regarded as one of the primary
indicators of a successful TKA. Rapid return of knee RoM
accompanied by earlier return to functional activities of
daily life was one of the potential effects of the interven-
tion applied in this study.
Continuous passive motion (CPM) is an external motor-
ised device, which enables a joint to move passively
throughout a preset arc of motion. Robert Salter intro-
duced the biological concept of CPM in the early 1980s
[3-6]. He demonstrated in rabbit knees that CPM
enhanced cartilage healing and regeneration compared to
prolonged articular rest. Coutts et al [7] first initiated CPM
use immediately after TKA. Their rationale was based on
Salter's research and the postulate that CPM enhanced col-
lagen tissue healing with better fibre orientation, avoiding
cross-linking and thus generating better movement resto-
ration.
CPM has been widely used as an adjunct to physiotherapy
(PT) after TKA for the past two decades. However, there is
still controversy as to whether it is useful. Various authors
recommend CPM [7-15], whereas others [16-23] have
found it to be of little value in the rehabilitation of the
knee after TKA.
Although several systematic reviews favour the use of
CPM in the first rehabilitation phase after surgery [24-26],
there still is substantial debate about the total period of
CPM application and the duration of individual sessions.
A Cochrane review [24] on the topic concluded that use of
CPM combined with PT offers beneficial results compared
to PT alone in the short-term rehabilitation after TKA. It
also suggested, however, that more research was required
to assess the differences in CPM effectiveness with differ-
ent characteristics of application, such as total duration of
treatment and intensity of CPM interventions.
Most studies have evaluated effects during the acute in-
hospital period. Before the year 2000, discharge from the
Maastricht University Hospital after TKA was scheduled
approximately 14 days after surgery. Nowadays, most
patients are discharged four days after surgery. Since the
time spent in hospital after surgery has decreased, contin-
uation of CPM after hospital discharge might be benefi-
cial. Although CPM is now increasingly being
administered in the postclinical home situation and is
beginning to become part of the usual care programme,
proper research into the effectiveness of a prolonged use
of CPM at home is still lacking [24,25]. The only study
that has been reported [20] compared CPM with PT as a
stand-alone therapy, whereas in the study presented here,
CPM was added to a standardised programme, adequately
reflecting current practice, as orthopaedic surgeons at the
hospital and physiotherapists at the hospital and at home
currently play an important role in the rehabilitation
process for TKA patients.
This study involved the same health care professionals
and the same treatment strategies that are currently in use
in the Netherlands, but one patient group additionally
received CPM at home.
The expected effect of CPM treatment was a quicker resto-
ration of RoM, resulting in improved ADL function during
the first three months after surgery. Knee flexion values of
95° and 105° are regarded as RoM benchmarks [27] in
the functional recovery after CPM. While 95° of knee flex-
ion allows normal ADL function, 105° of flexion provides
the opportunity to ride a bicycle. This is of great advantage
both in daily life, at least in the Netherlands, and in the
rehabilitation from TKA surgery, because cycling allows
patients to move the knee much more. We expected that
prolonged use of CPM at home would allow patients to
achieve these RoM benchmarks earlier in their recovery
process.
The study was conducted among patients with limited
RoM at the time of hospital discharge. We chose to
include this specific subgroup because we believed that
CPM might provide the greatest RoM gain in patients with
RoM limitations. Furthermore, several authors have stated
that patients with poorer function immediately after sur-
gery may well need more attention [28,29]. About 50% of
the patients undergoing one of the 160 TKAs performed
annually at the Maastricht University Hospital have less
than 80° of RoM four days after surgery and thereforeBMC Musculoskeletal Disorders 2008, 9:60 http://www.biomedcentral.com/1471-2474/9/60
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potentially meet the inclusion criteria of the proposed
study.
Objective
Continuous passive motion (CPM) has proved to increase
the amount of knee flexion for knee patients in the acute
hospital setting (5–10 days). The primary purpose of this
randomised controlled trial was to establish whether there
is additional longer-term benefit of continuing CPM after
hospital discharge.
Research question
What is the effect on range of motion and functional sta-
tus of prolonged use of a continuous passive motion
device at home in addition to PT, compared to PT alone,
in patients with limited flexion range of motion (less than
80°) of the knee at discharge from the hospital after total
knee arthroplasty?
Methods
Study design
A randomised controlled trial, with blinded treatment
allocation, assessment and analysis, was carried out, with
local medical ethics committee approval, to assess the
added value of prolonged CPM use at home, using func-
tion and mobility as the main outcomes.
Participants
Patients scheduled for unilateral primary TKA between
April 1st 2005 and June 30th 2006 in the 'Arthrose kliniek
Maastricht' (Maastricht osteoarthritis clinic) programme
at the Maastricht University Hospital, the Netherlands,
were invited to participate in the study. Subjects were con-
sidered eligible if they had less than 80° of RoM 4 days
after surgery, were able to understand and speak Dutch,
were not suffering from mental disabilities and were resi-
dent within the 'Maastricht Heuvelland' region. Patients
were excluded if they needed to stay in hospital for more
than five days after surgery or showed relevant co-morbid-
ity influencing mobility (e.g. claudication, other prosthe-
sis) or were operated upon by minimally invasive surgery.
Patients older than 80 years were also excluded. Eligible
patients were contacted one week before the planned sur-
gery, and were randomised into two groups after signing
an informed consent form.
Randomisation
Blocked and concealed randomisation with a block size of
four ensured equal distribution of patients over the two
treatment groups. Groups were prestratified on preopera-
tive flexion mobility of the knee.
Interventions
During the in-hospital period, all patients received a
standardised PT programme, involving 20 minutes of PT
and four hours of CPM use daily for four days. CPM was
already applied in the recovery room. Nurses installed the
CPM device following standardised procedures. CPM was
used for two consecutive hours, twice daily. One session
was performed in the evening in order to avoid interfering
with other daytime medical and rehabilitation activities.
After 5 minutes of warm-up, RoM was set as tolerated by
the patients. A description of the treatment protocol after
total knee surgery is available on the website of the PT
department of the Maastricht University Hospital [30].
At the end of the in-hospital period, all patients were ran-
domly assigned to one of the following groups: a control
group which received semi-standardised regular PT and an
experimental group which received the same PT interven-
tion in combination with two extra weeks of CPM treat-
ment for four hours daily. CPM was administered in the
same fashion as during hospital stay. Patients were able to
increase RoM by themselves. They kept a patient diary in
which they wrote the daily RoM increments as well as the
content and duration of their PT sessions, medication use
and pain perceived during the day and while on the CPM
machine.
From day 18 onward, all patients received regular PT treat-
ment until patients and therapists were satisfied with their
overall functioning.
The post-clinical PT was standardised in terms of treat-
ment objectives. All patients received treatment consisting
of active and passive mobilisation of the knee joint, active
strengthening of the m. quadriceps, and training of ADL
functions (gait, sit to stand and stair climbing). Mean
treatment session duration was 30 minutes, mean total of
treatment sessions
Outcome assessment
After collection of baseline variables before surgery and at
hospital discharge, outcome measures were assessed at 17
days, six weeks and three months after surgery, during
normal routine assessments at the orthopaedic clinic
(Table 1) or by visiting the patients at home. The outcome
assessor was blinded for the treatment procedure.
Primary outcome measures were:
1. functional status, using the WOMAC function score
[31,32] and the Knee Society Score [33]; and
2. range of motion, assessed with a long-arm goniometer
[34].
Secondary outcome measures were:
a. perceived effect, using a seven-point Likert scale;BMC Musculoskeletal Disorders 2008, 9:60 http://www.biomedcentral.com/1471-2474/9/60
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b. postoperative medication use (amount; type being
standardised);
c. satisfaction with treatment, on an 11-point Likert scale;
d. satisfaction with treatment result, on an 11-point Likert
scale;
e. adherence to treatment protocols and use of CPM (in
hours);
f. quantity, duration and nature of PT intervention.
The study design is depicted in Figure 1.
The first primary endpoint of the study was on day 17 after
surgery, which was the time when the experimental treat-
ment stopped and short-term effects were measured.
The second endpoint was at three months after surgery.
Table 1 shows the timing of the outcome assessment
RoM was measured actively as well as passively using a
large goniometer following the method described by Bro-
sseau [34]. The intraobserver reliability of this method for
knee flexion is 0.99, that for active extension 0.97, and the
criterion validity for knee flexion is 0.98, that for exten-
sion 0.42 [34].
Functional status was measured using two scales, the joint
specific Knee Society Scale (KSS) [33] and the disease-spe-
Table 1: Timing of the outcome assessment
T0 1 WEEK PRIOR 
TO SURGERY
T1 END OF 
CLINICAL PHASE
T2 17 DAYS AFTER 
SURGERY
T3 6 WEEKS AFTER 
SURGERY
T4 12 WEEKS AFTER 
SURGERY
R a n g e  o f  m o t i o n XXXXX
K n e e  S o c i e t y  S c o r e XXXXX
WOMAC X X X X
Perceived effect X X X
P a i n  m e d i c a t i o n XXXX
Satisfaction with 
treatment
XXX
Satisfaction with 
results
XXX
Adherence X
Quantity, duration 
and kind of treatment
XXX
Study design and outcome assessment Figure 1
Study design and outcome assessment. T0 baseline assessment, one week before surgery, T1 assessment 4 days after 
surgery, T2 assessment 17 days after surgery, T3 assessment 6 weeks after surgery T4 assessment 3 months after surgery, R = 
randomisation.
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cific Western Ontario and McMaster University Osteoar-
thritis index (WOMAC) [31].
The KSS is concise and easy to use. It represents a clear
attempt to separate knee function from overall patient
functional status. Bach et al [35] reported that the repro-
ducibility of the knee score is poor, whilst the function
score shows good reproducibility. The construct validity
of the KSS is good [36].
The WOMAC Osteoarthritis Index is a disease-specific
questionnaire developed specifically for people with oste-
oarthritis of the hip and knee. It is a self-administered, 3-
dimension, 24-item instrument. The three dimensions of
the WOMAC are pain, stiffness, and physical function.
Scoring of the WOMAC ranges from 'none' to 'extreme'.
Scale sum scores have been standardised (0–100), with
high values indicating less pain or better physical func-
tioning [32]. The WOMAC questionnaire is generally
acknowledged to have good validity, reliability and
responsiveness. We used the Dutch version of WOMAC
[32].
At follow-up, patients were asked to judge the effect of the
surgery on a seven-point Likert scale ranging from 'worse
than ever' status to 'completely recovered' [37].
Postoperative medication use and adherence to the treat-
ment protocols were measured using a patient diary.
The primary effect measurement was scheduled for the
17th day after surgery, while follow-up measurements
were scheduled at six weeks and three months after sur-
gery.
Power analyses
The number of subjects required to achieve statistical sig-
nificance was determined by means of a power analysis.
We assumed that a difference of more than 5° of knee
flexion mobility (SD 8°) at the end of the CPM applica-
tion would be clinically relevant. With an alpha of 0.05,
and a power of 80%, we needed 28 patients per group to
prove this.
Data analysis
Data was stored and analysed with SPSS-12.0 After checks
for missing values and normality, linear regression tech-
niques were applied by a blinded analyst using the 'inten-
tion-to-treat' principle. Primary and secondary outcome
measures were reported for the in-hospital and home sit-
uations, and for six-week and three-month follow-up.
Means and 95% confidence intervals were calculated.
The primary research question was tested using Student's
t-tests with a p-value of 0.05 being regarded as statistically
significant.
Results
Of the 147 patients who were scheduled for surgery
between April 1st 2005 and June 30th 2006, 60 were
included in the study. Thirty-five patients were not consid-
ered eligible, for the following reasons. Five patients were
not residents of the Maastricht region, 10 patients had rel-
evant co-morbidity or had RA as an underlying problem
and 20 patients were older than 80 years. Another 52
patients were excluded, for the following reasons: 32 were
excluded because their active knee RoM was over 80° at
T1; eight patients needed to stay in hospital for more than
five days after surgery and six were operated upon using
minimally invasive surgery. In four cases, surgery was
more extensive. Two patients refused to participate
because of bad experiences with CPM treatment during
the in-hospital period.
The baseline characteristics of the patients in the two
groups were similar in terms of clinical and demographic
characteristics.
All Patients were operated by one of two orthopaedic sur-
geons. One surgeon operated on 40 patients, equally
divided over both treatment groups. The other surgeon
performed the surgery in 20 cases, also equally divided
over both groups. Cemented Scorpio ps knee prosthesis
were used and the patella was resurfaced in all cases. Mean
operation time was 111 minutes, 109 (sd 20.7) in the
CPM+ PT group and 113 (sd 22.0) in the PT group.
Although we prestratified on preoperative active RoM
(strata > 100° <), mean preoperative flexion RoM was
slightly higher in the CPM group. At T1, RoM was similar
in both groups. Both groups also showed comparable lev-
els of functional ability (Tables 2 and 3).
Primary outcome measures
Range of motion
A trend in favour of prolonged CPM use was found at the
end of the treatment period. In terms of total RoM, the
CPM group achieved 5° more RoM than the PT group
(Table 4). RoM in the CPM group improved 6° more dur-
ing the active treatment period (17. 7° over 11. 6°).
At follow-up, these differences had faded. At six weeks and
three months, we could not detect any difference in RoM
between the two treatment strategies (Figure 3). In terms
of the number of patients achieving the flexion RoM
benchmarks of 95° and 105°, no differences were found
between the two groups at any of the outcome measure-
ments (Table 5).BMC Musculoskeletal Disorders 2008, 9:60 http://www.biomedcentral.com/1471-2474/9/60
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Functional status
Although the experimental group scored slightly better on
the KSS functional status score and the WOMAC func-
tional difficulty score, no significant differences were
found between the two groups, neither at day 17 nor at
either of the follow-up measurements (Tables 4 and 6).
Secondary outcome
No significant differences were found on any of the sec-
ondary outcome measures at any single outcome meas-
urement. Treatment content was similar in both groups,
as were the number of treatment sessions and the time
spent on individual sessions. As early as day 17, the
majority of the patients scored their status (perceived
effect) as 'better' compared to the situation before surgery.
Patients were generally satisfied with their individual
treatment and with treatment results (Table 7).
Adherence to the CPM intervention was very high: 29 of
the 30 patients followed the prescribed regimen. One
patient reduced CPM use to two hours from day 10
onwards, because her knee RoM was over 105°, and she
felt uncomfortable with four hours of CPM use when
reaching high degrees of flexion.
Complications
One subject in each group had to undergo knee manipu-
lation under anaesthesia between six weeks and three
months after surgery.
Secondary analyses on the subgroup of the patients hav-
ing less than 68° (0–50 percentile) of active RoM at dis-
charge showed that these patients benefited more from
CPM treatment. They improved 11° more in active
RoM(22° versus 11° in the PT group) during the active
treatment fortnight. However, these differences in range
of motion benefit had also faded at six-week follow-up.
Discussion
The present study demonstrated improvement in total
RoM at the end of the prolonged period of CPM use. How-
ever, this did not translate into any functional benefits.
Our findings thus suggest that, although CPM produces
benefits in knee RoM in the short term, it does not result
in additional RoM in the longer term, nor in any func-
tional gain. Since we did not find any difference in the
numbers of patients achieving the clinically important
benchmarks of 95° and 105°, neither at the end of the
treatment period nor at follow-up, it is doubtful whether
the additional degrees of RoM are of clinical importance.
Although our study population was a selection of patients
with limited RoM at discharge, our results confirm those
presented in systematic reviews [24,25], implying that
patients with limited RoM exhibit comparable improve-
ments to the basic population of patients after TKA. Our
hypothesis that this group might benefit more from the
CPM application was not supported. Our long-term 
Table 2: Subject characteristics and preoperative assessments of RoM and functional status
T0 PT + CPM N = 30 PT N = 30
Gender % female 60 70
Mean Sd Mean Sd
Age 64.1 8.1 65 9.1
Active RoM before surgery (flexion to extension) 104.9 13.8 100.7 13.2
Passive RoM before surgery 110.2 14.0 105.9 13.8
Active extension 4.8 4.6 6.2 5.0
Active flexion 109.7 12.1 106.9 12.3
Passive extension 3.3 4.3 4.7 4.3
Passive flexion 113.5 12.4 110.6 11.8
KSS knee 53.5 16.4 47.5 15.3
KSS function 61.5 10.6 52.3 18.7
WOMAC score 54.8 17.7 51.2 13.6
Pain subscale 10.6 4.7 10.5 3.1
Stiffness subscale 4. 0 1.9 3.8 2.1
Difficulty subscale 40. 2 13.2 36.9 11.7
Table 3: Baseline measurement (T1) of RoM and KSS
T1 PT + CPM N = 30 PT N = 30
Active RoM at T1 66.1 8.9 66.6 6.8
Passive RoM at T1 71.1 8.4 72.5 5.7
Active extension 8.9 4.4 8.1 4.4
Active flexion 75 6.9 74.7 4.5
Passive extension 6.7 4.1 6.1 4.2
Passive flexion 77.8 7.1 78.6 3.8
Knee society knee score at T1 55.9 17 50.0 17.6
Knee society function score at T1 25.8 14 26 13.5
T1 = day of discharge from the hospital, i.e. day 4 after surgeryBMC Musculoskeletal Disorders 2008, 9:60 http://www.biomedcentral.com/1471-2474/9/60
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Table 4: Primary outcome measurements on day 17
T2 ROM PT + CPM N = 30 PT N = 30 P VALUE 95% CI
Mean sd Mean sd
Active RoM at T2 83.6 11.4 78.6 8.7 0.06 -0.2 – 10.3
Passive RoM at T2 88.7 10.4 84.0 9.9 0.07 -0.5 – 10.0
Delta active RoM T1-T2 17.5 13.4 11.9 9.8 0.07 -0.5 – 11.6
Delta passive RoM T1-T2 17.6 12.9 11.6 9.4 0.04 0.02 – 11.9
Extension active 6.3 3.9 8.1 4.8 0.11 -4.1 – 0.4
Extension passive 4.3 3.1 5.7 4.6 0.17 -3.4 – 0.6
Flexion active 89.9 9.1 86.7 8.5 0.16 -1.4 – 7.8
Flexion passive 93 8.8 89.7 9.6 0.17 -1.4 – 8.1
KSS knee score 67.6 19.6 67.3 14.9 0.94 -8.7 – 9.3
KSS function score 43 14.6 39.8 21.1 0.50 -4.7 – 11.3
WOMAC score 69.9 15.9 65.4 16.4 0.28 -3.9 – 12.9
WOMAC pain 15.8 4.7 15.3 4.1 0.60 -2.9 – 1.7
WOMAC stiffness 5.0 1.8 4.8 1.6 0.66 -0.7 – 1.1
WOMAC difficulty 49.1 11.9 45.3 12.3 0.23 -2.5 – 10.1
T2 = 17 days after surgery
Flowchart of subjects through the trial Figure 2
Flowchart of subjects through the trial.
 
        Assessed for eligibility (n=148) 
 
   
  Excluded (n= 87) 
  Not meeting inclusion criteria   (n=85) 
Enrollment  Resident outside the region   5   
A g e          2 0    
Co-morbidity      10 
  RoM >80º at T1      32 
  Longer hospital stay    8 
Minimally invasive surgery  6  Randomisation    Extended  surgery    4
       
Refused to participate   (n= 2)
 
 
 
 
Allocated to CPM +PT intervention (n=30)  Allocated to PT intervention (n=30) 
 
 
 
 
 
 
Analysed (n=30) 
Excluded from analysis (n=0) 
Lost to follow-up (n=0) 
Discontinued intervention (n= 0) 
Received allocated intervention (n=30) 
Lost to follow-up (n=0) 
Discontinued intervention (n= 0) 
Received allocated intervention (n=30) 
     
Analysed (n=30) 
Excluded from analysis (n=0) 
Allocation 
Follow-Up 
Analysis BMC Musculoskeletal Disorders 2008, 9:60 http://www.biomedcentral.com/1471-2474/9/60
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results were comparable to those reported by others
[12,15,38]. Kumar et al [10] and Leach et al [23] reported
greater RoM at six-week follow-up. A possible explanation
might be that they included patients, regardless of RoM
and therefore found somewhat better RoM.
Like previous researchers [9,15,16,39], we did not detect
any differences in functional status between the groups.
The addition of CPM did not seem to lead to measurable
functional benefits. Denis et al [16] surmised that subjects
who received additional CPM could even have poorer
functional abilities, because they remained inactive dur-
ing the CPM interventions. We did not detect a decrease in
functional activities in the CPM group. A large proportion
of all subjects, regardless of research group allocation,
reported functional gains on all outcome measurements.
Patients with limited RoM in the early stages of recovery
seemed to consistently improve over time.
We chose total RoM as the outcome instead of focusing on
flexion RoM because several authors [8,40-42] have
already reported on adverse effects of CPM application on
extension range. Although extension RoM in our patients
was limited in the short term after TKA, we did not detect
any difference between the two groups. In fact, we found
slightly better extension RoM in the CPM group. Our
extension deficits were comparable to those already
reported by others [9,10,16,22].
We found small effects on range of motion at the end of
the active treatment period, which faded during four
weeks of follow-up in which the patients received regular
PT treatment. This suggests that although adding 14 days
of CPM is beneficial for short-term RoM, the improve-
ment does not last. An alternative hypothesis might be
that CPM treatment should be maintained for an even
longer period for effects to take root. Our study results do
not rule out this hypothesis.
Table 5: Number of patients reaching flexion benchmarks at T2 and T3
T2 17 DAYS AFTER SURGERY T3 6 WEEKS AFTER SURGERY
Group < 95° > < 105° > < 95° > < 105° >
CPM + PT 25 5 27 3 10 20 20 10
PT 24 6 28 2 10 20 22 8
Progress of active RoM through the trial period Figure 3
Progress of active RoM through the trial period.
105
66,6
83,6
91,9
101 101
66,6
78,6
91,8
101,2
65
75
85
95
105
pre-op discharge 17 days 6 weeks 12 weeks
Physiotherapy + CPM 
 
 
Physiotherapy BMC Musculoskeletal Disorders 2008, 9:60 http://www.biomedcentral.com/1471-2474/9/60
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Study limitations
Milne et al [24] suggested in their review that future
research should focus on the effects of different character-
istics of application, such as total duration of treatment
and intensity of CPM interventions, and on effects in dif-
ferent populations. We chose to include patients with lim-
ited range of motion at the end of the in-hospital period,
postulating that these patients might benefit most from
extra CPM treatment. Perhaps our choice of target popula-
tion was wrong. In any case, one should keep in mind that
our conclusions are limited to comparable populations,
post-clinical PT treatment and CPM application protocols
similar to those described in our clinical trial. This may be
obvious, but as several authors [43,44] have already
pointed out, the treatment approaches used after TKA vary
greatly among rehabilitation providers. The external
validity of our study may therefore be limited if protocols
differ greatly.
We protocolised the post-clinical PT in terms of treatment
objectives, leaving individual therapists some leeway to
specify these objectives at their own discretion. This may
have led to differences in treatment content between indi-
vidual therapists, which might have affected the contrast
between the two interventions. However, we did not
detect any major differences in PT treatment from the
patient diaries in which therapists wrote down the content
of the individual treatment sessions during the active
CPM treatment period.
CPM treatment in the home situation was a self-manage-
ment treatment. Patients received the CPM machine,
which was adjusted to their individual needs and charac-
teristics. Patients were instructed how to use it and for
how long. During the next fortnight, patients managed
treatment on their own or with the help of their spouses.
Although they were instructed to call the researcher if they
had any problems with the machine, this only occurred
twice. Although analysis of the patient diaries in which
they wrote daily CPM increments and usage time did not
indicate any misuse in CPM application, and although
self-management is usual care for at-home CPM use in the
Netherlands, it may have led to sub-maximal use of the
CPM device.
Table 7: Secondary outcome assessment on day 17
T2 ROM PT + CPM N = 30 PT N = 30 P value 95% CI
MEAN SD MEAN SD
Number of treatment sessions 4.8 1.5 5.1 1.4 0.43 -1.05 – 0.44
Duration per session 29.5 5.5 28.4 5.9 0.49 -2.0 – 4.13
Perceived effect 3.2 1.5 3.0 1.5 0.55 -0.5 – 1.0
Satisfaction with treatment 8.2 0.8 8.5 0.7 0.37 -1.0 – -0.1
Satisfaction with results 7.4 1.4 7.8 1.5 0.35 -1.2 – 0.3
Adherence 97% 100%
Table 6: Six-week and three-month follow-up
6 WEEKS 3 MONTHS
PT+CPM n = 30 Pt n = 30 P value 95ci PT+CPM n = 30 Pt n = 30 P value 95ci
Mean sd Mean sd Mean sd Mean sd
Active RoM 91.9 13.6 91.8 14.3 0.98 -7. – 7.3 100.9 4.8 102 4.3 0.78 -8.8 – 6.6
Passive RoM 96.9 13.4 95.5 14.2 0.69 -5. – 8.5 106.1 14.1 106.2 3.7 0.98 -7.5 – 7.3
Extension active 6.3 4.0 6.9 5.4 0.63 -3.0 – 1.8 4.8 3.9 4.3 4.7 0.61 -1.7 – 2.9
Flexion active 98.2 11.7 98.7 11.2 0.87 -6. – 5.4 105.7 2.5 106.2 0.6 0.99 -6.7 – 5.6
KSS knee score 77.3 14.9 73.6 13.8 0.33 -3.8 -11.1 80.4 5.3 78.8 9.2 0.72 -7.6 – 10.8
KSS function score 59.8 10.0 56.2 15.8 0.29 -3.2 – 0.5 72.4 11.4 65.5 2.1 0.15 -2.6 – 16.3
WOMAC score 75 13.6 74.5 16.1 0.89 -7.2 – 8.2 80.5 7.7 82.8 0.5 0.56 -10.5 – 5.5
WOMAC pain 16.0 3.7 16.6 4.0 0.53 -2.6 – 1.4 17.3 3.8 17.5 .9 0.83 -2.3 – 1.8
WOMAC stiffness 5.4 1.5 4.8 1.5 0.13 -0.2 – 1.4 5.5 1.4 5.3 1.6 0.49 -0.5 – 1.0
WOMAC difficulty 53.0 9.5 52.7 12.0 0.92 -5.3 – 5.9 57.6 4.2 58.6 8.4 0.74 -7.3 – 5.2
Perceived effect 2.3 0.76 2.4 0.85 0.87 -0.45 -.38 2.1 0.7 2.4 1.0 0.16 -0.73 – 0.14
Satisfaction with treatment 8.3 0.88 8.7 0.84 0.76 -0.85 -0.1 8.6 0.77 8.5 0.88 0.70 -0.35 – 0.52
Satisfaction with results 8.1 1.0 8.4 1.0 0.21 -0.85 -.18 8.6 0.8 8.2 1.5 0.20 -0.22 – 1.0BMC Musculoskeletal Disorders 2008, 9:60 http://www.biomedcentral.com/1471-2474/9/60
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Our study has many characteristics that contribute to the
validity of the results, such as comparability at baseline,
adherence to interventions and the use of one outcome
assessor to minimise noise due to problems of interob-
server reproducibility.
Conclusion
Although our results indicate that prolonged CPM use has
a short-term effect on RoM, standard implementation of
prolonged CPM use in patients with limited RoM at hos-
pital discharge should be reconsidered, since neither long-
term effects nor transfer to better functional performance
was detected.
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